BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/12/2014 11:15:00 AM | Browse: 1825 | Download: 2375
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Use of eltrombopag in thrombocytopenia of liver disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Vishal Sharma |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Vishal Sharma, Assistant Professor, Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh 160011, India. docvishalsharma@gmail.com |
| Key Words |
Cirrhosis; Thrombopoietin; Eltrombopag; Romiplostim; Hepatitis; Hepatitis C virus; Splenectomy; Thrombocytopenia |
| Core Tip |
Thrombocytopenia associated with liver disease is multifactorial. Eltrombopag, a thrombopoietin agonist, has been found useful in increasing platelet counts in these patients. It has been clinically used to increase platelet counts in cirrhotic patients prior to invasive procedures and in patients with chronic hepatitis C to enable administration of interferon based antiviral therapy. However, there are concerns regarding its safety and possible increased risk of portal vein thrombosis. |
| Publish Date |
2014-12-12 11:14 |
| Citation |
Sharma V. Use of eltrombopag in thrombocytopenia of liver disease. World J Pharmacol 2014; 3(4): 186-192
|
| URL |
http://www.wjgnet.com/2220-3192/full/v3/i4/186.htm |
| DOI |
http://dx.doi.org/10.5497/wjp.v3.i4.186 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.